Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Xtrana

1987 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Developer of nucleic acid-based tests developed so that nucleic acid-based detection systems can be utilized not only in traditional laboratory settings but also in point-of-care, point-of-service applications. The company's proprietary assays are used in drug discovery, detection of environmental and food contaminants, forensics and identity testing, human and animal diseases, genetic predisposition to disease, and other applications.

Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare
Other Industries
Other Healthcare Services
Laboratory Services (Healthcare)
Biotechnology
Acquirer
Primary Office
  • 590 Burbank Street
  • Suite 205
  • Broomfield, CO 80020
  • United States

Xtrana Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Xtrana‘s full profile, request access.

Request full access to PitchBook

Xtrana Executive Team (1)

Name Title Board
Seat
Contact
Info
Tim Dahltorp Chief Financial Officer & Chief Executive Officer